| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |